🔎 Trials Near Me

Hjem › Autoimmune sykdommer › Pennsylvania › Philadelphia

Kliniske studier for Autoimmune sykdommer i Philadelphia, PA

16 studier for Autoimmune sykdommer søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Autoimmunity After Checkpoint Blockade

RekruttererObservasjonsstudie
  • University of Pennsylvania - Abramson Cancer Center, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04119713

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RekruttererFase 3
  • Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RekruttererFase 2/3
  • Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
Alder 6 til 75 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06154252

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

RekruttererFase 2
  • Fox Chase Cancer Center- Temple BMT, Philadelphia
Alder 16 til 70 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT07328581

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

RekruttererFase 3
  • Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
  • Lewis Katz School of Medicine at Temple University, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06948318

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

RekruttererFase 3
  • GSK Investigational Site, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

RekruttererFase 1/2
  • Children's Hospital of Philadelphia, Philadelphia
Alder 18 til 65 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06121297

Abatacept for the Treatment of Giant Cell Arteritis

RekruttererFase 3
  • University of Pennsylvania, Philadelphia
Alder 50 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT04474847

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

RekruttererFase 3
  • The Children's Hospital of Philadelphia, Philadelphia
Alder 12 og eldre · Alle kjønn · Oppdatert 6. aug. 2026 · NCT06056297

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

RekruttererFase 2/3
  • Thomas Jefferson University Hospital, Philadelphia
Alder 18 til 75 · Alle kjønn · Oppdatert 29. jul. 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservasjonsstudie
  • Children's Hospital of Philadelphia, Philadelphia
  • Nemours - Alfred I. duPont Hospital for Children, Brandywine · 21 mi unna
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

RekruttererFase 1
  • Jefferson Einstein Hospital Philadelphia, Philadelphia
Alder 12 til 70 · Alle kjønn · Oppdatert 22. mai 2026 · NCT06308978

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

RekruttererFase 1
  • Temple University Hospital, Philadelphia
Alder 18 og eldre · Alle kjønn · Oppdatert 25. feb. 2026 · NCT06626919

Central Vein Sign in Multiple Sclerosis Extension Study

Rekrutterer
  • University of Pennsylvania, Philadelphia
Alder 18 til 65 · Alle kjønn · Oppdatert 20. feb. 2026 · NCT07424027

X-linked Moesin Associated Immunodeficiency

RekruttererObservasjonsstudie
  • Perelman School of medecine, Philadelphia
Alder 4 til 80 · Menn · Oppdatert 25. apr. 2025 · NCT06278337

Autoimmune sykdommer-studier i andre byer

Andre studier i Philadelphia

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.